Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Clinical Trial

Randomized Controlled Trial

Clinical Trial, Phase III

Comparative Study

Case Reports

Research Support, Non-U.S. Gov't

Research Support, N.I.H., Extramural

Meta-Analysis

Clinical Trial, Phase II

Multicenter Study

Publication Year

From

Quick links

Individual year

2021

2019

2017

2013

2011

2010

2006

2005

2004

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Lomustine""[mesh_terms]

18 Results

Searching titles within these results

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.

Norbert Galldiks, Veronika Dunkl, Garry Ceccon, Caroline Tscherpel, Gabriele Stoffels, Ian Law, Otto M Henriksen, Aida Muhic, Hans S Poulsen, Jan Steger, Elena K Bauer, Philipp Lohmann, Matthias Schmidt, Nadim J Shah, Gereon R Fink, Karl-Josef Langen

European journal of nuclear medicine and molecular imaging 2019;45(13):2377-2386

Full Text

Abstract

PCV chemotherapy for recurrent glioblastoma.

F Schmidt, J Fischer, U Herrlinger, K Dietz, J Dichgans, M Weller

Neurology 2006;66(4):587-9

Full Text

Abstract

Oligodendroglioma.

Thomas L Ellis, Volker W Stieber, Rebekah C Austin

Current treatment options in oncology 2004;4(6):479-90

Full Text

Abstract

Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding.

J Shamash, G Dancey, C Barlow, P Wilson, W Ansell, R T D Oliver

British journal of cancer 2005;92(1):36-40

Free Full Text

Abstract

Melanoma-associated retinopathy: does autoimmunity prolong survival?

C Chan, J O'Day

Clinical & experimental ophthalmology 2002;29(4):235-8

Full Text

Abstract

Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma.

J Valencak, W Dietrich, M Raderer, K Dieckmann, D Prayer, J A Hainfellner, C Marosi

Journal of neuro-oncology 2001;49(3):263-8

Full Text

Abstract

A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.

J Streffer, M Schabet, M Bamberg, E H Grote, R Meyermann, K Voigt, J Dichgans, M Weller

Journal of neurology 2000;247(4):297-302

Full Text

Abstract

Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.

A U Ty, S J See, J P Rao, J B K Khoo, M C Wong

Neurology 2006;66(2):247-9

Full Text

Abstract

Medulloblastomas and central nervous system primitive neuroectodermal tumors.

Thomas W McLean

Current treatment options in oncology 2004;4(6):499-508

Full Text

Abstract

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.

Wolfgang Wick, Patrick Roth, Christian Hartmann, Peter Hau, Makoto Nakamura, Florian Stockhammer, Michael C Sabel, Antje Wick, Susanne Koeppen, Ralf Ketter, Peter Vajkoczy, Ilker Eyupoglu, Rolf Kalff, Torsten Pietsch, Caroline Happold, Norbert Galldiks, Friederike Schmidt-Graf, Michael Bamberg, Guido Reifenberger, Michael Platten, Andreas von Deimling, Christoph Meisner, Benedikt Wiestler, Michael Weller

Neuro-oncology 2017;18(11):1529-1537

Free Full Text

Abstract

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

Roger J Packer, Amar Gajjar, Gilbert Vezina, Lucy Rorke-Adams, Peter C Burger, Patricia L Robertson, Lisa Bayer, Deborah LaFond, Bernadine R Donahue, MaryAnne H Marymont, Karin Muraszko, James Langston, Richard Sposto

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4202-8

Full Text

Abstract

Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.

Susan G R McDuff, Jorg Dietrich, Katelyn M Atkins, Kevin S Oh, Jay S Loeffler, Helen A Shih

Cancer medicine 2021;9(1):3-11

Free Full Text

Abstract

Adults with newly diagnosed high-grade gliomas.

D Croteau, T Mikkelsen

Current treatment options in oncology 2002;2(6):507-15

Full Text

Abstract

OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.

M Colombi, A Guffanti, A Alietti, M L Latargia, C Vener, A T Maiolo, L Baldini

Leukemia & lymphoma 2001;40(1-2):87-94

Full Text

Abstract

Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.

A O von Bueren, K von Hoff, M Benesch, S Rutkowski

Klinische Padiatrie 2010;221(6):396-7

Full Text

Results: 1 – 15 / 18

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Lomustine""[mesh_terms]

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.

PCV chemotherapy for recurrent glioblastoma.

Oligodendroglioma.

Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding.

Melanoma-associated retinopathy: does autoimmunity prolong survival?

Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma.

A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.

Oligodendroglial tumor chemotherapy using "decreased-dose-intensity" PCV: a Singapore experience.

Medulloblastomas and central nervous system primitive neuroectodermal tumors.

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.

Adults with newly diagnosed high-grade gliomas.

OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.

Dose reductions of vincristine in children with medulloblastoma treated in the maintenance arm of the prospective multicenter trial HIT'91.

Results for
""Lomustine""[mesh_terms]